Acute respiratory distress syndrome (ARDS) causes significant morbidity and mortality with no effective pharmacologic therapy. Protective lung ventilator strategies remain the mainstay of available treatment. New therapeutic nucleic acid scavenger compounds for the treatment of ARDS and methods of treatment of ARDS comprising administration of nucleic acid scavengers are provided.
